BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8506092)

  • 1. Infectious complications of bone marrow transplantation.
    Silber JL; Goldberg J
    N J Med; 1993 Apr; 90(4):303-6. PubMed ID: 8506092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prevention of infection after bone marrow transplantation].
    Schmeiser T
    Fortschr Med; 1991 Feb; 109(6):155-7. PubMed ID: 1646147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunoglobulin therapy in patients after autologous and allogeneic bone marrow transplantation].
    Körholz D; Grünewald S; Burdach S; Göbel U
    Infusionsther Transfusionsmed; 1993 Apr; 20 Suppl 1():68-71; discussion 72. PubMed ID: 8499754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pulmonary complications after bone marrow transplantation].
    Teschler H; Quabeck K; Schäfer UW; Konietzko N; Costabel U
    Pneumologie; 1994 Feb; 48(2):131-9. PubMed ID: 8183864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary complications following bone marrow transplantation.
    Chan CK; Hyland RH; Hutcheon MA
    Clin Chest Med; 1990 Jun; 11(2):323-32. PubMed ID: 2189666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Higher risk of cytomegalovirus and aspergillus infections in recipients of T cell-depleted unrelated bone marrow: analysis of infectious complications in patients treated with T cell depletion versus immunosuppressive therapy to prevent graft-versus-host disease.
    van Burik JA; Carter SL; Freifeld AG; High KP; Godder KT; Papanicolaou GA; Mendizabal AM; Wagner JE; Yanovich S; Kernan NA
    Biol Blood Marrow Transplant; 2007 Dec; 13(12):1487-98. PubMed ID: 18022579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Lung diseases following organ transplantation].
    Link H
    Pneumologie; 1990 Feb; 44 Suppl 1():409-11. PubMed ID: 2195525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review of vascularized bone marrow transplantation: current status and future clinical applications.
    Gordon CR; Tai CY; Suzuki H; Strande LF; Ramsamooj R; Matthews MS; Black KS; Hewitt CW
    Microsurgery; 2007; 27(4):348-53. PubMed ID: 17477415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Infections following bone marrow transplantation].
    Ljungman P; Andersson J; Sparrelid E
    Nord Med; 1995; 110(12):320-1. PubMed ID: 8524635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Composite vascularized skin/bone transplantation models for bone marrow-based tolerance studies.
    Ozmen S; Ulusal BG; Ulusal AE; Izycki D; Siemionow M
    Ann Plast Surg; 2006 Mar; 56(3):295-300. PubMed ID: 16508361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multicenter, randomized, double-blind comparison of different doses of intravenous immunoglobulin for prevention of graft-versus-host disease and infection after allogeneic bone marrow transplantation.
    Winston DJ; Antin JH; Wolff SN; Bierer BE; Small T; Miller KB; Linker C; Kaizer H; Lazarus HM; Petersen FB; Cowan MJ; Ho WG; Wingard JR; Schiller GJ; Territo MC; Jiao J; Petrarca MA; Tonetta SA
    Bone Marrow Transplant; 2001 Jul; 28(2):187-96. PubMed ID: 11509937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time of onset, viral load, relapse, and duration of active cytomegalovirus infection in bone marrow transplant outcomes.
    Habib K; Lamia T; Amel L; Abdelrahmen A; Saloua L; Hana E; Amine S; Bechir Z; Tarek BO; Assia BH
    Exp Clin Transplant; 2008 Mar; 6(1):67-73. PubMed ID: 18405248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of AB0-blood group incompatibility on the outcome of recipients of bone marrow transplants from unrelated donors in the Japan Marrow Donor Program.
    Kimura F; Sato K; Kobayashi S; Ikeda T; Sao H; Okamoto S; Miyamura K; Mori S; Akiyama H; Hirokawa M; Ohto H; Ashida H; Motoyoshi K;
    Haematologica; 2008 Nov; 93(11):1686-93. PubMed ID: 18835834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune reconstitution after purified autologous and allogeneic blood stem cell transplantation compared with unmanipulated bone marrow transplantation in children.
    Schwinger W; Weber-Mzell D; Zois B; Rojacher T; Benesch M; Lackner H; Dornbusch HJ; Sovinz P; Moser A; Lanzer G; Schauenstein K; Ofner P; Handgretinger R; Urban C
    Br J Haematol; 2006 Oct; 135(1):76-84. PubMed ID: 16925797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful renal transplantation following prior bone marrow transplantation in pediatric patients.
    Thomas SE; Hutchinson RJ; DebRoy M; Magee JC
    Pediatr Transplant; 2004 Oct; 8(5):507-12. PubMed ID: 15367289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A second prophylactic MHC-mismatched bone marrow transplantation protects against rat acute myeloid leukemia (BNML) without lethal graft-versus-host disease.
    Nestvold JM; Omdal BK; Dai KZ; Martens A; Benestad HB; Vaage JT; Rolstad B
    Transplantation; 2008 Jan; 85(1):102-11. PubMed ID: 18192919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of infection early after allogeneic stem cell transplantation on the risk of leukemic relapse and graft-versus-host disease.
    Kim SY; Lee DG; Kim MS; Kim HJ; Lee S; Min CK
    Am J Hematol; 2008 Oct; 83(10):784-8. PubMed ID: 18661492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Gastroenterological complications after bone marrow transplantation].
    Ratajczak MZ; Duziak M
    Pol Tyg Lek; 1990 Aug 20-27; 45(34-35):716-20. PubMed ID: 2075143
    [No Abstract]   [Full Text] [Related]  

  • 20. Bone marrow transplantation from genetically HLA-nonidentical donors in children with fatal inherited disorders excluding severe combined immunodeficiencies: use of two monoclonal antibodies to prevent graft rejection.
    Jabado N; Le Deist F; Cant A; De Graeff-Meeders ER; Fasth A; Morgan G; Vellodi A; Hale G; Bujan W; Thomas C; Cavazzana-Calvo M; Wijdenes J; Fischer A
    Pediatrics; 1996 Sep; 98(3 Pt 1):420-8. PubMed ID: 8784367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.